Medical Imaging Software Development: 10 Questions Before Hiring a Partner
The FDA says more than 1,600 AI-enabled medical devices had been authorized by September 2026. That makes “we build healthcare AI” a weaker vendor signal, not a stronger one.
This article outlines 10 critical questions to evaluate medical imaging software development partners, emphasizing regulatory compliance, interoperability, and security in AI-enabled healthcare systems.
What happened
The article presents a framework for evaluating medical imaging software development partners through 10 targeted questions, addressing technical, regulatory, and operational requirements for AI-enabled healthcare systems.
Why it matters
For AI developers and healthcare technology professionals, ensuring vendors meet strict regulatory and technical standards is essential to avoid costly rework, compliance failures, or safety risks in medical imaging systems.
- Prioritize vendors with demonstrable experience in DICOM/PACS and AI validation.
- Regulatory compliance and traceable evidence are critical for FDA-approved medical devices.
- Interoperability beyond DICOM (e.g., EHR integration) is essential for clinical workflows.
- Security must be engineered into the product lifecycle, not added as an afterthought.
- Clarify IP ownership and migration plans to avoid dependency risks.
The bigger picture
The article guides organizations in selecting reliable partners for medical imaging software, reducing risks related to regulatory non-compliance, interoperability failures, and security vulnerabilities in AI-driven healthcare systems.
The article provides a structured approach to evaluating medical imaging software partners, emphasizing technical rigor, regulatory compliance, and long-term system reliability in AI-enabled healthcare solutions.
Technical details
- DICOM and DICOMweb standards for medical image management
- PACS/VNA integration and modality worklists
- FDA Quality Management System Regulation (QMSR) compliance
- HL7/FHIR interoperability for clinical workflows
- AI model validation, observability, and rollback strategies
- Security mechanisms: RBAC, encryption, SBOMs, and vulnerability management
FAQ
What is the significance of the FDA's 1,600 AI-enabled device approvals mentioned in the article?
It underscores the growing prevalence of AI in healthcare, making vendor claims about AI capabilities less reliable and necessitating deeper technical evaluation.
Why are DICOM and PACS integration critical for medical imaging software?
These standards ensure seamless handling of medical images, clinical context, and interoperability with existing healthcare systems, which is vital for reliable AI applications.
How does the article address AI model validation in medical imaging?
It emphasizes separating model performance from clinical usefulness, requiring vendors to explain observability, rollback mechanisms, and human oversight in AI workflows.
This summary and analysis were generated with AI from the original article and may contain errors. Read the original for the full story.
Read the full story
Originally published by Dev.to AI on Oct 12, 2026.
Comments
Sign in to join the discussion.